EDS: Debate

EVENT TYPE
Education Dinner Series
DATE & TIME
Wednesday 6 December 2017, 5.30 for 6-9pm
LOCATION
The Grandstand Room 2, 1 Blackburn Circuit The University of Sydney
ORGANISER
Sydney Catalyst

Debate

"The next big thing in cancer needs a revolution not more evolution"

REGISTER HERE

The Grandstand
Room 2, 1 Blackburn Circuit, The University of Sydney
Three course dinner and beverages included.
RSVP by 27 November
For the Affirmative
Captain: Professor Neil Watkins 

Petre Chair of Cancer Biology, Lab-Head Cancer Developmental Biology, Garvan Institute of Medical Research
+ Hotshot Team to be announced

For the Negative
Captain: Professor John Sime

Director, Sydney Catalyst 
Director, NHMRC Clinical Trials Centre, The University of Sydney

Associate Professor Rachel Morton
Director, Heath Economics - NHMRC Clinical Trials Centre, The University of Sydney

Dr Anthony Joshua
Director of Cancer Services, St Vincent's Hospital
Conjoint Associate Professor, The University of New South Wales

About the Debate
The annual Sydney Catalyst End of Year Debate aims to be controversial,  thought provoking and invariably entertaining.
.
Team biographies

Professor John Simes

Professor John Simes, MBBS, MS, FRACP, MD, is a medical oncologist in neuro-oncology, clinical epidemiologist and biostatistician. As the Director of the NHMRC Clinical Trials Centre he leads an extensive research program aimed at improving health practice and health outcomes through better use of clinical trials research. As the founding Director of Sydney Catalyst, he brings together cross-disciplinary teams whose aims are to improve the outcomes of those affected by cancer, through discovery, new knowledge and the development and implementation of more effective cancer treatments, supportive care and preventive strategies. Professor Simes is a committed clinician and researcher, leading clinical trials and translational research in Australia and, through collaborations, across the world. 

After an impressive career spanning 30 years, John is still inspired when a good idea evolves into a trial that helps improve practice and gives patients better outcomes. 

Dr Anthony Joshua
Dr Anthony Joshua completed his medical oncology training at the Royal Prince Alfred hospital in Sydney, Australia before moving to Toronto, Canada to complete a PhD under the supervision of Dr Jeremy Squire in prostatic carcinogenesis, and a clinical Fellowship under Dr Ian Tannock. He joined the Department of Medical Oncology at Princess Margaret Cancer Centre in Toronto as a staff oncologist in late 2008, specialising in genito-urinary malignancy and melanoma with research interests in circulating tumour DNA, tumour heterogeneity, mechanisms of enzalutamide resistance and autophagy. He returned to Australia, joining the Kinghorn Cancer Centre and the Garvan Institute of Medical Research in late 2015. He is currently a conjoint Associate Professor with the University of New South Wales.
Despite obvious physical similarities in stature and physique, he is not related to the current world heavyweight champion.
.
Associate Professor Rachel Morton
Associate Professor Rachael Morton is a health economist at the NHMRC Clinical Trials Centre, and Principal Research Fellow, Sydney Medical School, University of Sydney. She has a Masters in Clinical Epidemiology and PhD in health economics and completed her post-doc at The University of Oxford under the supervision of Professor Alistair Gray. Rachael was a Board member of the Australia and New Zealand Melanoma Trials Group (ANZMTG) for 9 years, and has research interests in economic evaluation alongside clinical trials, diagnostic test evaluation, and incorporation of patient reported outcomes measures (PROMs) into routine care. Rachael has published >100 papers, and in her spare time is an advocate for gender equity in STEMM - (Science Technology Engineering Mathematics and Medicine). 
Her personal evolution has involved flares, shoulder pads, lace and leg warmers…